Back to User profile » Dr Yoshio Sumida
Paper published by Dr Yoshio Sumida:
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis
Seko Y, Nishikawa T, Umemura A, Yamaguchi K, Moriguchi M, Yasui K, Kimura M, Iijima H, Hashimoto T, Sumida Y, Okanoue T, Itoh Y
Diabetes, Metabolic Syndrome and Obesity 2018, 11:835-843
Published Date: 27 November 2018